The most common side effects reported with GLP-1 receptor agonists include nausea, vomiting, constipation, and mild digestive discomfort, particularly during the dose escalation phase
Both medications are fully approved in the UK for the treatment of obesity
Mechanistic Focus in Research Within controlled laboratory settings, BPC-157/TB-500 is commonly studied in relation to peptide-mediated signalling networks and cellular regulatory mechanisms
Decorin A small proteoglycan that organizes collagen fibers into ordered, functional structures
Patients are "better served" by an expert, such as a weight-loss physician or primary care doctor, who can closely monitor them while taking these drugs, the doctor suggested, especially with the risk of certain side effects, like nausea or pancreatitis